Search Results

There are 111951 results for: content related to: Endpoints of hepatitis B treatment

  1. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26856

  2. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  3. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27532

  4. You have free access to this content
    Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 435–444, Yi-Cheng Chen, Chia-Ming Chu and Yun-Fan Liaw

    Article first published online : 29 SEP 2009, DOI: 10.1002/hep.23348

  5. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection

    Liver International

    Volume 31, Issue 9, October 2011, Pages: 1373–1380, Yu-Ru Tseng, Jia-Feng Wu, Yen-Hsuan Ni, Huey-Ling Chen, Chih-Cheng Chen, Wan-Hsin Wen, Hong-Yuan Hsu and Mei-Hwei Chang

    Article first published online : 28 JUN 2011, DOI: 10.1111/j.1478-3231.2011.02574.x

  6. You have free access to this content
    Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood

    Hepatology

    Volume 63, Issue 1, January 2016, Pages: 74–82, Jia-Feng Wu, Yu-Chun Chiu, Kai-Chi Chang, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu and Mei-Hwei Chang

    Article first published online : 29 OCT 2015, DOI: 10.1002/hep.28222

  7. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 9, September 2010, Pages: 1498–1506, Hui Ma, Rui-feng Yang and Lai Wei

    Article first published online : 3 FEB 2010, DOI: 10.1111/j.1440-1746.2010.06282.x

  8. You have free access to this content
    HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B

    Hepatology

    Volume 47, Issue 2, February 2008, Pages: 428–434, Michael W. Fried, Teerha Piratvisuth, George K. K. Lau, Patrick Marcellin, Wan-Cheng Chow, Graham Cooksley, Kang-Xian Luo, Seung Woon Paik, Yun-Fan Liaw, Peter Button and Matei Popescu

    Article first published online : 7 JAN 2008, DOI: 10.1002/hep.22065

  9. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Article first published online : 26 JAN 2007, DOI: 10.1002/hep.21513

  10. You have free access to this content
    Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion

    Liver International

    Volume 30, Issue 4, April 2010, Pages: 512–520, George K. K. Lau

    Article first published online : 19 JAN 2010, DOI: 10.1111/j.1478-3231.2009.02198.x

  11. An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients

    Journal of Viral Hepatitis

    Volume 18, Issue 7, July 2011, Pages: e184–e190, X. Zhang, S.-m. Lin, F. Ye, T.-y. Chen, M. Liu, Y.-r. Chen, S.-q. Zheng, Y.-r. Zhao and S.-l. Zhang

    Article first published online : 13 JAN 2011, DOI: 10.1111/j.1365-2893.2010.01423.x

  12. Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e41–e47, J. H. Kwon, J. W. Jang, S. Lee, J. Lee, K. W. Chung, Y. S. Lee and J. Y. Choi

    Article first published online : 20 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01509.x

  13. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Article first published online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  14. You have free access to this content
    Identification of a unique double-negative regulatory T-cell population

    Immunology

    Volume 134, Issue 4, December 2011, Pages: 434–447, Byung O. Lee, Joyce E. Jones, Cory J. Peters, David Whitacre, Lars Frelin, Janice Hughes, Won-Keun Kim and David R. Milich

    Article first published online : 4 NOV 2011, DOI: 10.1111/j.1365-2567.2011.03502.x

  15. You have free access to this content
    Poster Session 3: Hepatitis B: Epidemiology and Natural History History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 961A–1001A,

    Article first published online : 7 OCT 2015, DOI: 10.1002/hep.28233

  16. You have free access to this content
    Review article: current antiviral therapy of chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 10, November 2011, Pages: 1145–1158, W. S. Ayoub and E. B. Keeffe

    Article first published online : 7 OCT 2011, DOI: 10.1111/j.1365-2036.2011.04869.x

  17. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients

    Journal of Viral Hepatitis

    Volume 19, Issue 11, November 2012, Pages: 801–810, L. Kosi, T. Reiberger, B. A. Payer, K. Grabmeier-Pfistershammer, R. Strassl, A. Rieger and M. Peck-Radosavljevic

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01601.x

  18. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Article first published online : 7 OCT 2015, DOI: 10.1002/hep.28243

  19. Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 724–731, J. W. Shin, S. W. Jung, B. R. Park, C. J. Kim, J. B. Eum, B. G. Kim, I. D. Jeong, S.-J. Bang, S.-H. Lee, S. R. Kim and N. H. Park

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01599.x

  20. Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 2, March 2005, Pages: 216–221, N. H. Park, J. W. Shin, J. H. Park, S-J. Bang, D-H. Kim, K. R. Joo and D. H. Kim

    Article first published online : 17 FEB 2005, DOI: 10.1111/j.1365-2893.2005.00602.x